Literature DB >> 15831055

Update on Lassa fever in West Africa.

.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 15831055

Source DB:  PubMed          Journal:  Wkly Epidemiol Rec        ISSN： 0049-8114


× No keyword cloud information.
  5 in total

1.  Safety, immunogenicity, and efficacy of the ML29 reassortant vaccine for Lassa fever in small non-human primates.

Authors:  Igor S Lukashevich; Ricardo Carrion; Maria S Salvato; Keith Mansfield; Kathleen Brasky; Juan Zapata; Cristiana Cairo; Marco Goicochea; Gia E Hoosien; Anysha Ticer; Joseph Bryant; Harry Davis; Rasha Hammamieh; Maria Mayda; Marti Jett; Jean Patterson
Journal:  Vaccine       Date:  2008-08-08       Impact factor: 3.641

2.  Yellow fever 17D-vectored vaccines expressing Lassa virus GP1 and GP2 glycoproteins provide protection against fatal disease in guinea pigs.

Authors:  Xiaohong Jiang; Tim J Dalebout; Peter J Bredenbeek; Ricardo Carrion; Kathleen Brasky; Jean Patterson; Marco Goicochea; Joseph Bryant; Maria S Salvato; Igor S Lukashevich
Journal:  Vaccine       Date:  2010-12-08       Impact factor: 3.641

3.  A ML29 reassortant virus protects guinea pigs against a distantly related Nigerian strain of Lassa virus and can provide sterilizing immunity.

Authors:  Ricardo Carrion; Jean L Patterson; Curtis Johnson; Monica Gonzales; Carmen R Moreira; Anysha Ticer; Kathleen Brasky; Gene B Hubbard; Dmitry Moshkoff; Juan Zapata; Maria S Salvato; Igor S Lukashevich
Journal:  Vaccine       Date:  2007-02-27       Impact factor: 3.641

Review 4.  Review of the literature and proposed guidelines for the use of oral ribavirin as postexposure prophylaxis for Lassa fever.

Authors:  Daniel G Bausch; Christiane M Hadi; Sheik Humarr Khan; Juan J L Lertora
Journal:  Clin Infect Dis       Date:  2010-11-08       Impact factor: 9.079

5.  Delays in childhood immunization in a conflict area: a study from Sierra Leone during civil war.

Authors:  Charles Senessie; George N Gage; Erik von Elm
Journal:  Confl Health       Date:  2007-12-09       Impact factor: 2.723
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.